| Serial Number | 99315665 |
| Word Mark | EMYRA |
| Filing Date | Friday, August 1, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Friday, August 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genetic test results, predicting how patients will metabolize drugs, and tailoring patient treatment plans based on patient genetics to improve efficacy and minimize side effects; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for tailoring patient treatment plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genetic test results to optimize drug therapy; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for accessing and analyzing clinical guidelines, drug label annotations, and FDA drug label data to inform treatment plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing DNA test results to ensure optimal drug selection and dosing; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for clinical decision support for medical providers; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for integration with electronic health record systems of medical providers; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing gene-drug, drug-drug, food-drug interactions and nutrigenomics data to optimize drug therapy and nutrition plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing current and proposed patient treatment plans to identify known interactions between drugs that could lead to reduced effectiveness or adverse reactions; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing current and proposed patient treatment plans to identify dietary elements that may interfere with how medications are absorbed or metabolized; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing patient genetic test results related to nutrient metabolism and generating personalized dietary guidance to optimize health and support medication regimens |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 1, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sherpa Rx, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Nashville, TN 37206 |
| Event Date | Event Description |
| Friday, August 1, 2025 | NEW APPLICATION ENTERED |
| Friday, August 1, 2025 | APPLICATION FILING RECEIPT MAILED |